First Time Loading...

Sorrento Therapeutics Inc
NASDAQ:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
NASDAQ:SRNE
Watchlist
Price: 0.3322 USD 8.92% Market Closed
Updated: Jun 3, 2024

Sorrento Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sorrento Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Sorrento Therapeutics Inc
NASDAQ:SRNE
Net Change in Cash
-$13m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$11.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$218m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$21.9B
CAGR 3-Years
-140%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$126.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sorrento Therapeutics Inc's Net Change in Cash?
Net Change in Cash
-13m USD

Based on the financial report for Dec 31, 2022, Sorrento Therapeutics Inc's Net Change in Cash amounts to -13m USD.

What is Sorrento Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
34%

Over the last year, the Net Change in Cash growth was 34%.